BCLC Stage B Hepatocellular Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09037 | Pembrolizumab | 0 | Terminated | 1 |
DB11714 | Durvalumab | 1 | Recruiting | 1 |
DB11771 | Tremelimumab | 1 | Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Withdrawn | 1 |
DB00112 | Bevacizumab | 2 | Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Terminated | 1 |
DB08875 | Cabozantinib | 2 | Withdrawn | 1 |
DB14776 | Camrelizumab | 2 | Recruiting | 1 |
DB11574 | Elbasvir | 2 | Completed | 1 |
DB15149 | Futibatinib | 2 | Recruiting | 1 |
DB11575 | Grazoprevir | 2 | Completed | 1 |
DB06186 | Ipilimumab | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Completed | 1 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Terminated | 1 |
DB00811 | Ribavirin | 2 | Completed | 1 |
DB14765 | Rivoceranib | 2 | Recruiting | 1 |
DB00936 | Salicylic acid | Not Available | Not Yet Recruiting | 1 |